Font Size: a A A
Keyword [Intermediate-risk]
Result: 21 - 40 | Page: 2 of 3
21. Clinical Efficacy And Prognostic Factors Of Postoperative Radiotherapy And Chemotherapy In 150 Early-stage Cervical Cancer Patients With Intermediate Risk Factors
22. The Relationship Between The Different Level Of Preablative TSH And Its Response To 131I Therapy In Patients With Low To Intermediate Risk Differentiated Thyroid Cancer
23. The Prediction Value Of Tavc/Lavc On I-131 Whole Body Scan For Thyroid Remnant Ablation With Low Doses 131I-iodine In Low Or Intermediate Risk Differentiated Thyroid Carcinoma
24. The Application Value Of New Stratified Method In The Treatment Of Non-high-risk Acute Pulmonary Embolism With Adequate Anticoagulant Therapy
25. Analysis Of The Clinicopathological Data And Prognosis Of Stage ?b??a Cervical Cancer Patients With Intermediate-risk Factors
26. Analysis Of The Short-term Efficacy Of Very Low Dose Dicitabine In The Treatment Of Myelodysplastic Syndrome In The Low And Intermediate Risk Groups
27. Current Status Of Adjuvant Treatment For Early Cervical Cancer After Operation In Some Hospitals In Mainland China
28. A Comparative Study Of Different Doses Of 131I Remnant Ablation In Patients After Thyroidectomy For Intermediate Risk Differentiated Thyroid Cancer
29. Therapeutic Value Of Low-dose Decitabine In Patients With Intermediate-risk-2/High-risk MDS With ECOG Score>2-?3
30. Clinical Significance Of Gleason Score,T Stage And PSAD In Predicting PSA Progression After Radical Prostatectomy For Intermediate-risk Prostate Cancer
31. The Effect Of Intermediate Risk Factors On The Choice Of ?a-?a Cervical Cancer's Postoperative Adjuvant Therapy
32. Clinical Observation Of Yiqi Wenyang Bushen Rrescription In The Treatment Of Patients With Low Risk Or Intermediate Risk-1 Myelodysplastic Syndrome
33. The Relationship Between Different Adjuvant Treatment And Prognosis Of 350 Cases ?B-?A Cervical Squamous Cell Carcinoma Patients With Intermediate Risk Factors After Radical Resection
34. Efficacy And Recurrence Rate Of Different Doses Of 131I For Remnant Ablation In Low-and Intermediate-risk Differentiated Thyroid Cancer:A Meta-analysis
35. Study On The Correlation Between Nailfold Microcirculation And Blood Stasis Syndrome Of Grade 1 Low- And Intermediate-risk Hypertension
36. Clinical Study Of Yisui Granule In The Treatment Of 48 Patients With Low- And Intermediate-risk Myelodysplastic Syndromes
37. A Randomized Controlled Trial Of The Comprehensive Antihypertensive ABC Regimen Of Traditional Chinese Medicine In The Treatment Of Grade 1 Low- And Intermediate-risk Hypertension
38. A Study On The Adjuvant Chemotherapy Decision In Intermediate Risk Breast Cancer Patients
39. Moderate Risk Factors In The Midlife And Senile Patients With Cervical Cancer Postoperative Implement Disparate Adjuvant Therapy Prognosis Of Correlation Analysis
40. Identification Of Optimal Candidates For Active Surveillance For Intermediate-risk Prostate Cancer
  <<First  <Prev  Next>  Last>>  Jump to